News

Alnylam reiterates 2025 guidance with projected 36% growth in TTR franchise revenues
Q1 2025 Management View CEO Yvonne Greenstreet highlighted a robust start to 2025, with $469 million in combined net product ...
CHMP gives positive opinion on marketing authorization variation for Amvuttra
The EMA’s Committee for Medicinal Products for Human Use adopted a positive opinion, recommending a change to the terms of the marketing ...